Metomidate

Metomidate is a non-barbiturate imidazole that was discovered by Janssen Pharmaceutica in 1965^[1] and under the names (Hypnodil, Nokemyl) is sold as a sedative-hypnotic drug used in Europe to treat humans and for veterinary purposes.^[2]

Metomidate

Clinical data
ATCvet code	QN05CM94 (WHO)
Legal status
Legal status	In general: ℞ (Prescription only)
Identifiers
IUPAC name methyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate
CAS Number	5377-20-8 N
PubChem CID	21474
ChemSpider	20182 Y
UNII	Z18ZYL8Y51
ChEMBL	ChEMBL494039 Y
CompTox Dashboard (EPA)	DTXSID1048411
ECHA InfoCard	100.023.971
Chemical and physical data
Formula	C13H14N2O2
Molar mass	230.267 g·mol−1
3D model (JSmol)	Interactive image
SMILES O=C(OC)c1cncn1C(c2ccccc2)C
InChI InChI=1S/C13H14N2O2/c1-10(11-6-4-3-5-7-11)15-9-14-8-12(15)13(16)17-2/h3-10H,1-2H3 Y Key:FHFZEKYDSVTYLL-UHFFFAOYSA-N Y
NY (what is this?)  (verify)

¹¹C-labelled metomidate (11C-metomidate), may be used with positron emission tomography (PET). For instance, to detect tumors of adrenocortical origin.^[3][4]

See also

• Etomidate
• Propoxate